Navigation Links
YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
Date:3/13/2009

MISSISSAUGA, ON, March 13 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported that its poster entitled, "Binding properties of the anti-EGFR monoclonal antibody, nimotuzumab, limit interaction with the EGFR in renal and epidermal cells", has been accepted for presentation at the American Association for Cancer Research's (AACR) 100th Annual Meeting in Denver, Colorado on April 20th, 2009 (Abstract # 2763; Hall B-F, Poster Section 31; Session ID: Clinical Research 10).

The abstract of this poster has been published today (09-AB-5492-AACR).

"Data to be presented at the AACR and ESMO conferences, combined with rash being reported independent of the KRAS status of patients, are in sharp contrast to the dated speculation that toxicity is a marker for efficacy of EGFR-targeting agents," said David Allan, Chairman and CEO of YM BioSciences. "The data we present show the monovalent binding to normal cells of other antibodies confirming that only nimotuzumab will avoid severe rash, hypomagnesemia and the other debilitating toxicities common with the marketed antibodies. Consequently, nimotuzumab's benign safety profile makes it the anti-EGFR agent of choice for chronic use."

The objectives of the study to be presented at AACR were to examine whether the cause of the toxicities seen with currently marketed anti-EGFR antibodies, particularly severe skin rash and hypomagnesemia, were the result of properties intrinsic to the individual antibodies or to the class. The results show that Erbitux(R) binds to normal cells because it is capable of monovalent binding to very low expressions of EGFR whereas nimotuzumab's monovalent binding is transient. It is this transient monovalent binding that results in its benign safety profile. Both antibodies bind definitively when binding bivalently.'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
2. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
3. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
4. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
5. YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia
6. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
7. Chipscreen Biosciences and HUYA Bioscience Intl Announce Promising Preclincial and Phase I Solid Tumor/Lymphoma Data for Chidamide/HBI-8000, New HDAC Inhibitor for Cancer
8. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
9. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
10. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
11. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)...  Alere Inc. (NYSE: ALR ), a ... today in support of President Barack Obama,s ... global leader in rapid diagnostics for infectious disease, we ... address the serious threat of antibiotic resistance. We look ... initiatives to promote the development of rapid point-of-care tests ...
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... , Sept. 19, 2014  The body of ... the publication of two papers this past week.  The ... Head and Neck Surgery , finds that withholding ... subjective measures of sleep disordered breathing, leading the paper,s ... in obstructive sleep apnea severity and improvement of quality ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4
... Amex: CXM ) today provided an update regarding ... assets in connection with a proposed asset purchase under Chapter ... 27, 2011, the completion of such an asset purchase is ... bankruptcy court.  In an effort to expedite the proposed transaction, ...
... The National Association of Boards of ... Americans about the serious dangers associated with medicines purchased ... on Internet drug outlets found that 96% of 8,000 ... compliance with United States pharmacy laws, fuel prescription drug ...
Cached Medicine Technology:Cardium Reports on Transdel Transaction 2Cardium Reports on Transdel Transaction 3Cardium Reports on Transdel Transaction 4NABP Issues Rogue Online Pharmacy Public Health Alert 2NABP Issues Rogue Online Pharmacy Public Health Alert 3NABP Issues Rogue Online Pharmacy Public Health Alert 4
(Date:9/21/2014)... of preterm birth the birth of an infant ... significant health problem that has increased over the past ... Control and Prevention (CDC), preterm birth affects nearly 500,000 ... in the U.S. While medical care has improved survival ... positively impact the neurodevelopmental outcomes of preterm infants. , ...
(Date:9/21/2014)... of the leading online stores of real and synthetic hair ... human hair lace wigs inspired by 6 famous celebrities. It’s ... latest celebrity hairstyles are. , For people who ... to choose from: a style of yaki straight lace wig, ... ombre red lace wig. People can go to the product ...
(Date:9/21/2014)... public health authorities focus on the physical activity benefits ... of Montreal reveals that for children, playing has no ... activity that is fun, done alone or with friends, ... pleasure, but also to combat boredom, sadness, fear, or ... play, authorities put aside several aspects of play that ...
(Date:9/21/2014)... Dry roasted peanuts are more likely to trigger an ... University study involving mice. , The researchers say that ... the dry roasting process are recognised by the body,s ... allergic immune response the next time it sees any ... the number of people with peanut allergies in the ...
(Date:9/21/2014)... The Laboratory Testing Services industry is composed ... on items ranging from consumer and food products to ... operators to ensure the safety and quality of their ... government safety regulations and consumer lawsuits have led to ... revenue briefly dipped in 2009 as the US economy ...
Breaking Medicine News(10 mins):Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 2Health News:Research evaluates neurodevelomental and medical outcomes in single family room NICU 3Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:Dry roasting could help trigger peanut allergy 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... 3 Nanophase Technologies (Nasdaq: ... and advanced nanoengineered products, announced today that the Company ... 28th, as its Chief Technology Officer, so that he ... was responsible for several of the Company,s key patents ...
... National Center for Health Care Informatics (NCHCI) Presented Pilot ... a Patriot Scientific company (OTC Bulletin Board: PTSC), announced ... and the National Center for Health Care Informatics (NCHCI), ... a presentation today by Raymond F. Rogers, chief executive ...
... brand made specifically for kids by kids and their ... WAT-AAH!, the first sugar-free, functional water brand made specifically ... first official "WAT-AAH! Challenge" to defy the expectation that ... the month of March, mothers who participate in the ...
... released today by Dr. Jane L. Delgado, President and ... nation,s leading Hispanic health advocacy group."We congratulate Governor Sebelius ... Health and Human Services and Nancy-Ann DeParle on her ... Health Reform."The nation will be well served at this ...
... Inc. (Nasdaq: GTIV ), a leading provider ... plans to present at two upcoming investor conferences. Gentiva ... in Miami, Florida from 9:30 a.m. to 9:55 a.m. ... Annual Raymond James Institutional Investor Conference in Orlando, Florida ...
... meal of the day has surprising impact on young ... awareness for the importance of breakfast for students, Sodexo, ... more than 470 school districts across the country, has ... Students" in time for National School Breakfast Week, March ...
Cached Medicine News:Health News:Nanophase Announces Changes in Principal Officers and Directors 2Health News:Nanophase Announces Changes in Principal Officers and Directors 3Health News:Crossflo Health Information Exchange Project Presented at HP Health and Life Sciences Symposium 2Health News:Crossflo Health Information Exchange Project Presented at HP Health and Life Sciences Symposium 3Health News:Let Water Be Water, LLC Introduces New 'WAT-AAH! Challenge' 2Health News:National Alliance for Hispanic Health Congratulates Governor Kathleen Sebelius and Nancy-Ann DeParle 2Health News:Gentiva(R) Health Services to Present at Upcoming Investor Conferences 2Health News:Gentiva(R) Health Services to Present at Upcoming Investor Conferences 3Health News:Sodexo Shares Top Breakfast Benefits for Students 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: